International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890324) titled 'A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Jiangsu Guiqiong Pharmaceutical Co., Ltd.

Condition: Cachexia-Anorexia Syndrome Cachexia Cancer

Intervention: Drug: SXRN Injection Drug: SXRN Injection

Recruitment Status: Not recruiting

Phase: Phase 2

Date of F...